Cargando…
Real-world treatment patterns, patient-reported outcomes, and effectiveness of flexibledosing etanercept in patients with plaque psoriasis in Greece
Etanercept is approved for continuous or intermittent use and flexible dosing in plaque psoriasis (PsO). The objectives of this study were to investigate real-world treatment patterns with etanercept in Greek adults with moderate-to-severe PsO. This non-interventional multicenter study included a re...
Autores principales: | Rigopoulos, Dimitris, Patsatsi, Aikaterini, Antoniou, Christina, Sotiriadis, Dimitrios, Schulze, Angeliki Roussaki-, Boubouchairopoulou, Nadia, Skiadas, Ioannis, Tsekouras, Vasillios, Hernandez Daly, Ana Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724636/ https://www.ncbi.nlm.nih.gov/pubmed/36483226 http://dx.doi.org/10.4081/dr.2022.9265 |
Ejemplares similares
-
Serum Levels of TNF-α, IL-12/23p40, and IL-17 in Plaque Psoriasis and Their Correlation with Disease Severity
por: Kyriakou, Aikaterini, et al.
Publicado: (2014) -
Etanercept in the treatment of plaque psoriasis
por: Nguyen, Thao U, et al.
Publicado: (2009) -
Serum Levels of TNF-α, IL-12/23 p40, and IL-17 in Psoriatic Patients with and without Nail Psoriasis: A Cross-Sectional Study
por: Kyriakou, Aikaterini, et al.
Publicado: (2014) -
The safety of etanercept for the treatment of plaque psoriasis
por: Papp, Kim A
Publicado: (2007) -
Interstitial Granulomatous Dermatitis: Another Clinical Variant
por: Patsatsi, Aikaterini, et al.
Publicado: (2011)